Bristol-Myers Squibb Company PFD CONV 2
BMYMP
Get informed when a big investor buys or sells
+ FollowMarket Cap$814.59B
Close$
Share Statistics
| Market cap | $814.59 Billion |
|---|---|
| Enterprise Value | $848.99 Billion |
| Dividend Yield | $2.00 (4.26%) |
| Earnings per Share | $3.46 |
| Beta | 0.27 |
| Outstanding Shares | 2,042,000,000 |
Return
| Return on Equity | 41.59% |
|---|---|
| Return on Assets | 10.59% |
| Return on Invested Capital | 17.75% |
Valuation & Multiples
| P/E Ratio | 13.02 |
|---|---|
| PEG | 8.5 |
| Price to Sales | 16.67 |
| Price to Book Ratio | 40.0 |
| Enterprise Value to Revenue | 17.26 |
| Enterprise Value to EBIT | 69.34 |
| Enterprise Value to Net Income | 91 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 1.93 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bristol-Myers Squibb Co.
30,250 employees
CEO: Giovanni Caforio Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.